Fosun Pharma (2196 HK)

317

Analysis

Health Care • China

Fosun Pharma is a global innovation-driven healthcare group with core businesses in pharmaceutical manufacturing and R&D, medical devices and diagnosis, and healthcare services. The company focuses on therapeutic areas such as oncology, immunology, and central nervous system disorders, offering products like Artesun® and Yi Kai Da. It was founded in 1994 and is headquartered in Shanghai, China.

Refresh

Exchange Announcement • 12 Oct 2026 16:31

Date Of Board Meeting

Exchange Announcement • 25 Sep 2026 17:04

Next Day Disclosure Return - Share Buyback

Exchange Announcement • 24 Sep 2026 17:15

Next Day Disclosure Return - Share Buyback

Exchange Announcement • 22 Sep 2026 17:39

Next Day Disclosure Return - Share Buyback

Exchange Announcement • 21 Sep 2026 17:33

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00